Sec. 1. 17-A MRSA §1102, first ¶, as enacted by PL 1975, c. 499, §1, is amended to read:

For the purposes of defining crimes under this chapter and of determining the penalties therefor, there are hereby establishd established the following schedules, designated W, X, Y and Z.

Sec. 2. 17-A MRSA §1102, sub-§1, ¶M, as amended by PL 1997, c. 487, §1, is further amended to read:

M. Lysergic acid amide; and

Sec. 3. 17-A MRSA §1102, sub-§1, ¶N, as enacted by PL 1997, c. 487, §2, is amended to read:

N. Flunitrazepam or its chemical equivalent.; and

Sec. 4. 17-A MRSA §1102, sub-§1, ¶O is enacted to read:

O.__Unless listed or described in another schedule, the following hallucinogenic drugs or their salts, isomers and salts of isomers whenever the existence of the salts, isomers and salts of isomers is possible within the chemical designation:

(1)__3, 4 - methylenedioxy amphetamine, MDA;

(2)__5__methoxy - 3, 4 methylenedioxy amphetamine, MMDA;

(3)__3, 4, 5 - trimethoxy amphetamine, TMA;

(4)__4 - methyl - 2, 5 - dimethoxyamphetamine, DOM;

(5)__2, - 3 methylenedioxyamphetamine;

(6)__2, 5 - dimethoxyamphetamine, DMA;

(7)__4 - bromo - 2, 5 - dimethoxyamphetamine, DOB;

(8)__4 methoxyamphetamine;

(9)__3, 4 - methylenedioxy methamphetamine, MDMA;

(10)__4 - bromo - 2, 5 - dimethoxyphenethylamine, NEXUS;

(11)__3, 4 - methylenedioxy-N-ethylamphetamine, MDE;